This topic contains a solution. Click here to go to the answer

Author Question: Behavioral contract is a. an event that typically precedes the target response. b. accomplished ... (Read 71 times)

anshika

  • Hero Member
  • *****
  • Posts: 510
Behavioral contract is
 
  a. an event that typically precedes the target response.
  b. accomplished by reinforcing closer and closer approximations of the desired response.
  c. a systematic approach to changing behavior through the application of the principles of conditioning.
  d. a written agreement outlining a promise to adhere to the contingencies of a program.

Question 2

Shaping is
 
  a. an event that typically precedes the target response.
  b. accomplished by reinforcing closer and closer approximations of the desired response.
  c. a systematic approach to changing behavior through the application of the principles of conditioning.
  d. a written agreement outlining a promise to adhere to the contingencies of a program.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Smiles0805

  • Sr. Member
  • ****
  • Posts: 305
Answer to Question 1

C

Answer to Question 2

B




anshika

  • Member
  • Posts: 510
Reply 2 on: Jun 22, 2018
Excellent


bdobbins

  • Member
  • Posts: 326
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In Eastern Europe and Russia, interferon is administered intranasally in varied doses for the common cold and influenza. It is claimed that this treatment can lower the risk of infection by as much as 60–70%.

Did you know?

The immune system needs 9.5 hours of sleep in total darkness to recharge completely.

Did you know?

The B-complex vitamins and vitamin C are not stored in the body and must be replaced each day.

Did you know?

Essential fatty acids have been shown to be effective against ulcers, asthma, dental cavities, and skin disorders such as acne.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library